Prognoza choroby Alzheimera je ôgōlnie słaba, pōniywoż je to postympujōnce i zwyrodnieniowe schorzynie, co go niy idzie wyleczyć.
Wszyjske te ôczyniŏ, co wpływajōm na funkcjōniyrowanie ôrganizmu, sōm zawarte we wspōłczesnym systymie informacyjnym.
W miara postympu choroby ôsoby mogōm doświadczać utroty pamiyńci, ciynżkości z jynzykiym i kōmunikacyjōm, dezoriyntacyje jak tyż zmian w nastrōnie i zachowaniu.
W kōńcu mogōm niy poradzić sie ô siebie zadbać i potrzebować ôgōlnoczasowyj pōmocy.
Strzednio ôczekowano dugość życio po diagnozie wynosi kole 8-10 lot, ale może sie ôgraniczać w znŏleżności ôd wieku danego ôsoby, ôgōlnego stanu zdrowia i inkszych faktorōw.
Chocioż niy ma na to lyku, terapie mogōm pōmōc w kōntakcie z ôbjawami i poprawić jakość życio chorych na niy.
Kaldjian LC: Survival versus prognosis in Alzheimer disease. Ann Intern Med. 2004, 141 (7): 575; author reply 575.
Mayeux R, Stern Y, Sano M: Heterogeneity and prognosis in dementia of the Alzheimer type. Bull Clin Neurosci. 1985, 50 (): 7-10.
DeKosky ST, Golde T: Cerebrospinal Biomarkers in Alzheimer Disease-Potential Roles as Markers of Prognosis and Neuroplasticity. JAMA Neurol. 2016, 73 (5): 508-10.
Yaffe K: Treatment of Alzheimer disease and prognosis of dementia: time to translate research to results. JAMA. 2010, 304 (17): 1952-3.
Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.
Malpetti M, Joie R, Rabinovici GD: Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials. J Nucl Med. 2022, 63 (6): 830-832.
Schaeffer EL, Figueiro M, Gattaz WF: Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics (Sao Paulo). 2011, 66 Suppl 1 (): 45-54.
Bhagwat N, Pipitone J, Voineskos AN, Chakravarty MM: An artificial neural network model for clinical score prediction in Alzheimer disease using structural neuroimaging measures J Psychiatry Neurosci. 2019, 44 (4): 246-260.
Vermunt L, van Paasen AJL, Teunissen CE, Scheltens P, Visser PJ, Tijms BM: Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal. Neurology. 2019, 92 (23): e2699-e2705.
Raji MA, Brady SR: Mirtazapine for treatment of depression and comorbidities in Alzheimer disease. Ann Pharmacother. 2001, 35 (9): 1024-7.
['Zrzeczynie sie: medyczne']
['Ta strōna internetowo je dostympno ino we cylu edukacyjnym i informacyjnym i niy stanowi doradztwa medycznego ani profesjonalnych usug.']
['Informacyje podane niy winny być używane do diagnozowanio abo lyczynio problymu abo choroby, a ôsoby szukajōnce ôsobistej pōmocy medycznyj winny skōntrolować sie z licencjōnowanym medykiym.']
['Należy pamiyntać, iże neuralno neca, co gyneruje ôdpowiedzi na pytania, je ekstra niydokładno, kej sie rozchodzi ô treść numeryczno, bp. liczba ôsōb ze zdiagnozowanōm kōnkretnōm chorobōm.']
['Dycki szukejcie pōmocy u swojigo medyka abo inkszego wykwalifikowanego dochtora we sprawie stanu medycznego. Niy lekcewożcie profesjonalnyj rady medycznyj ani niy ôpōźnijcie sie z szukaniym jij skuli czegoś, co żeście poczytali na tyj strōnie. Jeźli myślicie, iże mogōm mieć niybezpieczyństwo medyczne, zazwōńcie na 911 abo udajcie sie zaroz do nojbliższyj izby wytrzyźwiyń. Żodno relacyjo medyk-pacjynt niy ma stworzōno bez ta strōna abo jeji użycie. Ani BioMedLib, ani jeji robotniki, ani żodyn inkszy autor tyj strōny niy skłodo żodnych zapewniyń, wyrażōnych ani dorozumianych, w ôdniesiyniu do informacyji podanych tukej abo do jeji użycio.']
['Ôdŏwanie praw autorskich']
['Digital Millennium Copyright Act z 1998 roku, 17 U.S.C. § 512 (the DMCA) zapewnio prawo do regresu posiedzicielōm praw autorskich, kerzi uwożajōm, iże materyjo ukazujōnco sie w Internecie naruszo jejich prawa na mocy amerykańskigo prawa autorskigo. ']
['Jeźli wierzicie w dobryj wierze, iże jake ino treści abo materyje udostympniōne w zwiōnzku z naszom witrynōm abo naszymi usugami naruszajōm wasze prawa autorskie, możecie (abo wasz przedstawiciel) posłać nōm zawiadōmiynie z prośbōm ô usuniyńcie tych treści abo materyji abo zablokowanie do nich dostympu.']
['Zawiadōmiynia muszōm być posłane we formie pisymnyj bez email (adres email zob. sekcyjŏ "Kōntakt").']
['DMCA wymogo, coby Twoje zawiadōmiynie ô rzekōmyj naruszynie praw autorskich zawiyrało nastympujōnce informacyje: (1) ôpis roboty chroniōnyj prawami autorskimi, co je przedmiotym rzekōmyj naruszynio; (2) ôpis rzekōmyj naruszajōncyj zawartości i informacyje stykajōnce, coby przizwolić nōm na zlokalizowanie zawartości; (3) informacyje kōntaktowe ô Tobie, w tym Twōj adres, numer telefonu i adres e-mail; (4) ôświadczynie ôd Ciebie, iże wiysz we dobro wierze, iże zawartość we spōsobie, co ô nim sie skarżysz, niy ma autoryzowano ôd posiedziciela praw autorskich abo jego agynta, ani bez żodne prawo.']
['5) oświadczynie złożōne bez Ciebie, podpisane pod sztrŏfōm fałszywyj ôświadczyniŏ, iże informacyje zawarte we zawiadōmiyniu sōm akuratne i iże posiadasz uprawniynia do egzekwowaniŏ uprawniyń, co ône sōm rzekōmo naruszane;']
['i (6) fizyczny abo elektrōniczny podpis posiedziciela praw autorskich abo ôsoby upoważniōnyj do fungowanio w jego imiyniu. ']
['Niyôstawiynie wszyjskich powyższych informacyji może skutkować ôpōźniyniym we rozpatrzeniu skargi.']
['Kōnakt']
['Proszymy ô e-mail z kożdym pytaniym abo sugestijōm.']
What is prognosis of alzheimer?
The prognosis of Alzheimer's disease is generally poor, as it is a progressive and degenerative condition with no known cure.
The rate of progression varies from person to person, but the disease typically worsens over time, leading to a decline in cognitive and physical abilities.
As the disease progresses, individuals may experience memory loss, difficulty with language and communication, disorientation, and changes in mood and behavior.
Eventually, they may become unable to care for themselves and require full-time assistance.
The average life expectancy after diagnosis is around 8-10 years, but this can vary widely depending on the individual's age, overall health, and other factors.
While there is no cure, treatments and therapies can help manage symptoms and improve quality of life for those with Alzheimer's disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Ôkoło']
['BioMedLib używo zautōmatyzowanych kōmputrōw (algorytmōw uczynia maszin) do gynerowanio porōw pytań i ôdpowiedzi.']
['Zaczynōmy ôd 35 milijōnōw publikacyji biōmedycznych z PubMed/Medline.']
